Deerfield Management Company, L.P. (Series C) Merus N.V. Put Options Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.04 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MRUS
# of Institutions
202Shares Held
63MCall Options Held
297KPut Options Held
117K-
Rtw Investments, LP New York, NY4.17MShares$168 Million2.86% of portfolio
-
Commodore Capital LP New York, NY3.87MShares$156 Million16.32% of portfolio
-
Wellington Management Group LLP Boston, MA3.5MShares$141 Million0.03% of portfolio
-
Samlyn Capital, LLC New York, NY2.67MShares$107 Million1.81% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.13MShares$85.4 Million1.3% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $1.84B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...